FRANCISCO JAVIER
LÓPEZ LONGO
Investigador ata 2019
Hospital Virgen del Camino
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen del Camino (9)
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
2015
-
Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus
Lupus, Vol. 24, Núm. 7, pp. 720-729
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1